Pharmacokinetics of recombinant human lipocalin-type prostaglandin D synthase/β-trace in canine

Neuroscience Research

Volumn 61, Issue 3, 2008, Pages 289-293

  Li, Weidong ^a   Mase, Mitsuhito ^b   Inui, Takashi ^c   Shimoda, Minoru ^d   Isomura, Kenichi ^b   Oda, Hiroshi ^e   Yamada, Kazuo ^b   Urade, Yoshihiro ^a  

^a OSAKA BIOSCIENCE INSTITUTE   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c Osaka City University   (Japan)

^d TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^e Maruha Nichiro Holdings Inc   (Japan)

Author keywords

Cerebrospinal fluid; Intrathecal injection; Intravenous injection; Prostaglandin D2; Serum; Urinary excretion rate

Indexed keywords

BETA TRACE ENZYME; ISOMERASE; LIPOCALIN; PROSTAGLANDIN D SYNTHASE;

ANIMAL EXPERIMENT; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DOG; FEMALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; URINARY EXCRETION;

ANIMALS; DOGS; FEMALE; HALF-LIFE; HUMANS; INJECTIONS, INTRAMUSCULAR; INTRAMOLECULAR OXIDOREDUCTASES; LIPOCALINS; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 44149098469     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2008.03.006     Document Type: Article

References (30)

1. 125I RIHSA to circulating plasma: a test for communicating hydrocephalus. Neurology 18 (1968) 870-874
2. Beuckmann C.T., Aoyagi M., Okazaki I., Hirorike T., Toh H., Hayaishi O., and Urade Y. Binding of biliverdin, bilirubin, and thyroid hormones to lipocalin-type prostaglandin D synthase. Biochemistry 38 (1999) 8006-8013
3. Beuckmann C.T., Lazarus M., Gerashchonko D., Mizoguchi A., Nomura S., Mohri I., Uesugi A., Kaneko T., Mizuno H., Hayaishi O., and Urade Y. Cellular localization of lipocalin-type prostaglandin D synthase (beta-trace) in the central nervous system of the adult rat. J. Comp. Neurol. 428 (2000) 62-78
4. Clark J.F., Reilly M., and Sharp F.R. Oxidation of bilirubin produces compounds that cause prolonged vasospasm of rat cerebral vessels: a contributor to subarachnoid hemorrhage-induced vasospasm. J. Cereb. Blood Flow Metab. 22 (2002) 472-478
5. Clausen J. Proteins in normal cerebrospinal fluid not found in serum. Proc. Soc. Exp. Biol. Med. 107 (1961) 170-172
6. Cutler R.W., Page L., Galicich J., and Watters G.V. Formation and absorption of cerebrospinal fluid in man. Brain 91 (1968) 707-720
7. Davies B., and Morris T. Physiological parameters in laboratory animals and humans. Pharm. Res. 10 (1993) 1093-1095
8. Eder, Supko J.G., Clark J.W., Puchalski T.A., Garcia-Carbonero R., Ryan D.P., Shulman L.N., Proper J., Kirvan M., Rattner B., Connors S., Keogan M.T., Janicek M.J., Fogler W.E., Schnipper L., Kinchla N., Sidor C., Phillips E., Folkman J., and Kufe D.W. Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily. J. Clin. Oncol. 20 (2002) 3772-3784
9. Fisher J.W. Erythropoietin: physiology and pharmacology update. Exp. Biol. Med. (Maywood) 228 (2003) 1-14
10. Hoffmann A., Conradt H.S., Gross G., Nimtz M., Lottspeich F., and Wurster U. Purification and chemical characterization of b-trace protein from human cerebrospinal fluid: its identification as prostaglandin D synthase. J. Neurochem. 61 (1993) 451-456
11. Inui T., Mase M., Emi M., Nakau H., Seiki K., Oda H., Yamada K., and Urade Y. Lipocalin-type prostaglandin D synthase in cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage scavenges bile pigments. Int. Congr. Ser. 1233 (2002) 447-451
12. Kranc K.R., Pyne G.J., Tao L., Claridge T.D., Harris D.A., Cadoux-Hudson T.A., Turnbull J.J., Schofield C.J., and Clark J.F. Oxidative degradation of bilirubin produces vasoactive compounds. Eur. J. Biochem. 267 (2000) 7094-7101
13. Maack T., Johnson V., Kau S.T., Figueiredo J., and Sigulem D. Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Kidney Int. 16 (1979) 251-270
14. Mase M., Yamada K., Iwata A., Matsumoto T., Seiki K., Oda H., and Urade Y. Acute and transient increase of lipocalin-type prostaglandin D synthase (beta-trace) level in cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage. Neurosci. Lett. 270 (1999) 188-190
15. Nagata A., Suzuki Y., Igarashi M., Eguchi N., Toh H., Urade Y., and Hayaishi O. Human brain prostaglandin D synthase has been evolutionarily differentiated from lipophilic-ligand carrier proteins. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 4020-4024
16. Oda H., Shiina Y., Seiki K., Sato N., Eguchi N., and Urade Y. Development and evaluation of a practical ELISA for human urinary lipocalin-type prostaglandin D synthase. Clin. Chem. 48 (2002) 1445-1453
17. Oikawa S., Inuzuka C., Kuroki M., Matsuoka Y., Kosaki G., and Nakazato H. Cell adhesion activity of non-specific cross-reacting antigen (NCA) and carcinoembryonic antigen (CEA) expressed on CHO cell surface: homophilic and heterophilic adhesion. Biochem. Biophys. Res. Commun. 164 (1989) 39-45
18. 125I-labelled beta-trace protein, with special reference to synthesis within the central nervous system. J. Neurochem. 21 (1973) 1153-1159
19. Piotin M., Mounayer C., Spelle L., Williams M.T., and Moret J. Endovascular treatment of anterior choroidal artery aneurysms. Am. J. Neuroradiol. 25 (2004) 314-318
20. Segrave A.M., Mager D.E., Charman S.A., Edwards G.A., and Porter C.J. Pharmacokinetics of recombinant human leukemia inhibitory factor in sheep. J. Pharmacol. Exp. Ther. 309 (2004) 1085-1092
21. Sheffield W.P., Marques J.A., Bhakta V., and Smith I.J. Modulation of clearance of recombinant serum albumin by either glycosylation or truncation. Thromb. Res. 99 (2000) 613-621
22. Tanaka T., Urade Y., Kimura H., Eguchi N., Nishikawa A., and Hayaishi O. Lipocalin-type prostaglandin D synthase (beta-trace) is a newly recognized type of retinoid transporter. J. Biol. Chem. 272 (1997) 15789-15795
23. Trinchard-Lugan I., Ho-Nguyen Q., Bilham W.M., Buraglio M., Ythier A., and Munafo A. Safety, pharmacokinetics and pharmacodynamics of recombinant human tumour necrosis factor-binding protein-1 (Onercept) injected by intravenous, intramuscular and subcutaneous routes into healthy volunteers. Eur. Cytokine Netw. 12 (2001) 391-398
24. Urade Y., Fujimoto N., and Hayaishi O. Purification and characterization of rat brain prostaglandin D synthetase. J. Biol. Chem. 260 (1985) 12410-12415
25. Urade Y., Kitahama K., Ohishi H., Kaneko T., Mizuno N., and Hayaishi O. Dominant expression of mRNA for prostaglandin D synthase in leptomeninges, choroid plexus, and oligodendrocytes of the adult rat brain. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 9070-9074
26. Urade Y., Eguchi N., and Hayaishi O. In: Lipocalins, Åkerström B., Borregaard N., Flower D.R., and Salier J.P. (Eds). Lipocalin-type prostaglandin D synthase as an enzymic lipocalin (2006), Landes Bioscience/Eurekah.com, Gergetown, TX 99-109
27. Urlaub G., and Chasin L.A. Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity. Proc. Natl. Acad. Sci. U.S.A. 77 (1980) 4216-4220
28. Watanabe K., Urade Y., Mader M., Murphy C., and Hayaishi O. Identification of β-trace as prostaglandin D synthase. Biochem. Biophys. Res. Commun. 203 (1994) 1110-1116
29. Welch K., and Friedman V. The cerebrospinal fluid valves. Brain 83 (1960) 454-469
30. Yamaoka K., Tanigawara T., Nakagawa T., and Uno T. A pharmacokinetic analysis program (multi) for microcomputer. J. Pharmacobiodyn. 4 (1981) 879-885